Cardiome Pharma Corporation Pre-Tax Profit Margin 2016-2019 | CORV
Cardiome Pharma Corporation pre-tax profit margin from 2016 to 2019. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Pre-Tax Profit Margin Historical Data |
Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
2019-09-30 |
$0.03B |
$-0.04B |
-123.33% |
2019-06-30 |
$0.03B |
$-0.03B |
-110.00% |
2019-03-31 |
$0.03B |
$-0.02B |
-62.07% |
2018-12-31 |
$0.03B |
$-0.02B |
-58.62% |
2018-09-30 |
$0.03B |
$-0.02B |
-66.67% |
2018-06-30 |
$0.03B |
$-0.02B |
-69.23% |
2018-03-31 |
$0.03B |
$-0.03B |
-123.08% |
2017-12-31 |
$0.02B |
$-0.03B |
-125.00% |
2017-09-30 |
$0.02B |
$-0.03B |
-116.67% |
2017-06-30 |
$0.02B |
$-0.03B |
-113.04% |
2017-03-31 |
$0.02B |
$-0.02B |
-104.35% |
2016-12-31 |
$0.03B |
$-0.02B |
-76.00% |
2016-09-30 |
$0.02B |
$-0.02B |
-91.30% |
2016-06-30 |
$0.02B |
$-0.02B |
-95.65% |
2016-03-31 |
$0.02B |
$-0.02B |
-95.65% |
2015-12-31 |
$0.02B |
$-0.03B |
-119.05% |